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Abstract
Kamocki K, N€or JE, Bottino MC. Dental pulp stem cell
responses to novel antibiotic-containing scaffolds for
regenerative endodontics. International Endodontic Journal,
48, 1147–1156, 2015.
Aim To evaluate both the drug-release profile and
the effects on human dental pulp stem cells’ (hDPSC)
proliferation and viability of novel bi-mix antibiotic-
containing scaffolds intended for use as a drug deliv-
ery system for root canal disinfection prior to regener-
ative endodontics.
Methodology Polydioxanone (PDS)-based fibrous
scaffolds containing both metronidazole (MET) and
ciprofloxacin (CIP) at selected ratios were synthesized
via electrospinning. Fibre diameter was evaluated
based on scanning electron microscopy (SEM) images.
Pure PDS scaffolds and a saturated CIP/MET solution
(i.e. 50 mg of each antibiotic in 1 mL) (hereafter
referred to as DAP) served as both negative (nontoxic)
and positive (toxic) controls, respectively. High-perfor-
mance liquid chromatography (HPLC) was performed
to investigate the amount of drug(s) released from the
scaffolds. WST-1 proliferation assay was used to
evaluate the effect of the scaffolds on cell proliferation.
LIVE/DEAD assay was used to qualitatively assess
cell viability. Data obtained from drug release and
proliferation assays were statistically analysed at the
5% significance level.
Results A burst release of CIP and MET was noted
within the first 24 h, followed by a sustained mainte-
nance of the drug(s) concentration for 14 days. A
concentration-dependent trend was noticed upon
hDPSCs’ exposure to all CIP-containing scaffolds,
where increasing the CIP concentration resulted in
reduced cell proliferation (P < 0.05) and viability. In
groups exposed to pure MET or pure PDS scaffolds, no
changes in proliferation were observed.
Conclusions Synthesized antibiotic-containing scaf-
folds had significantly lower effects on hDPSCs prolif-
eration when compared to the saturated CIP/MET
solution (DAP).
Keywords: antibiotic pastes, drug delivery, nanofi-
bres, regeneration, root canal, stem cells.
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Introduction
Treatment of pulpal necrosis of immature permanent
teeth is challenging due to its uncertain prognosis
(Andreasen et al. 2002, Ribeiro et al. 2008). Recently,
regenerative endodontics has become a rational alter-
native to classical root apexification (Banchs & Trope
2004). It relies on copious chemical canal irrigation
with minimal or no mechanical root canal prepara-
tion, followed by the application of a mixture of anti-
biotics for nearly 1 month (Banchs & Trope 2004,
Geisler 2012). During the next visit, canal contents
are removed via irrigation, and bleeding from periapi-
cal tissue is prompted (Murray et al. 2007).
The evoked bleeding leads to the accumulation of
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undifferentiated stem cells (Lovelace et al. 2011),
which, according to the literature, can play an impor-
tant role in the regeneration of pulpal tissues (Murray
et al. 2007, Diogenes et al. 2014). Overall, this inno-
vative endodontic procedure has led, according to
clinical cases and case series, to increased root length,
apical closure and continuing thickness of dentine
walls, amongst other positive clinical findings (Banchs
& Trope 2004, Kim et al. 2010, Petrino et al. 2010,
Lin et al. 2013, Simon & Smith 2014).
One of the most critical steps in regenerative endodon-
tics is the complete eradication of residual infection
(Albuquerque et al. 2014). Typically, this is achieved by
the application of calcium hydroxide. As an alternative,
triple antibiotic paste (TAP) containing CIP, MET, and
minocycline or double antibiotic paste (DAP), containing
CIP and MET, are used (Hoshino et al. 1996, Sato et al.
1996). Notably, the use of both calcium hydroxide and
antibiotic pastes has demonstrated several important
side effects. The former has been associated with root
weakening when used for both short (Sahebi et al.
2010, Yassen et al. 2013) and long (Andreasen et al.
1989, Yassen et al. 2013, Moazami et al. 2014) periods
of time. On the other hand, the use of clinically
recommended dosages of TAP and DAP pastes has led to
unfavourable effects on dental pulp cells (Ruparel et al.
2012, Chuensombat et al. 2013), as well as periodontal
ligament fibroblasts (Yadlapati et al. 2014), posing
important questions towards the predictability of regen-
erative procedures. Moreover, current irrigation meth-
ods do not completely remove the remnants of antibiotic
pastes from root canals (Berkhoff et al. 2014).
In the light of this, drug delivery-based strategies, to
reduce the local drug concentration through the use of
antibiotic-containing nanofibres, have been proposed
recently (Bottino et al. 2011, 2013a, 2014, Albuquer-
que et al. 2014, Palasuk et al. 2014, Waeiss et al.
2014). Therefore, the hypotheses of the study were
that the amount of drug(s) released from these novel
antibiotic-containing scaffolds (i) would lead to
reduced cell toxicity, and more importantly (ii), it
would diminish the negative impact on hDPSC prolifer-
ation when compared to the double antibiotic (DAP)
paste (i.e. ciprofloxacin and metronidazole mixture).
Materials and methods
Fabrication of the antibiotic-containing scaffolds
The synthesis of antibiotic-containing nanofibrous
scaffolds has been described in detail (Bottino et al.
2011, 2013a, 2014, Palasuk et al. 2014, Waeiss et al.
2014). Briefly, MET (Sigma-Aldrich, St. Louis, MO,
USA), and CIP (Sigma-Aldrich) bi-mix polydioxanone-
based (PDS II, Ethicon, Somerville, NJ, USA) solutions
were prepared to obtain distinct MET/CIP-containing
scaffolds. Pure MET and CIP scaffolds were also pre-
pared. PDS pieces were dissolved in 1,1,1,3,3,3-hexa-
fluoro-2-propanol (HFP, Sigma-Aldrich). MET and CIP
were added alone and in different ratios (by weight,
wt.%) into the PDS solutions and mixed overnight
(Bottino et al. 2013a, Palasuk et al. 2014). The follow-
ing groups of scaffolds were prepared: pure MET, pure
CIP, 3:1MET/CIP, 1:1MET/CIP and 1:3MET/CIP
(Palasuk et al. 2014). All antibiotic-containing PDS
solutions were incorporated with 25 wt.% of antibiotic
(s) in total relative to the PDS polymer weight (i.e.
150 mg of drug(s) in total) (Bottino et al. 2013a). Pure
PDS scaffolds and a saturated CIP/MET solution (i.e.
50 mg of each antibiotic in 1 mL) (DAP) (Sabrah et al.
2013) served as negative (nontoxic) and positive
(toxic) controls, respectively. Antibiotic-containing
solutions and pure PDS were loaded into 5-mL syrin-
ges (Becton-Dickinson, Franklin Lakes, NJ, USA) fitted
with 27G metallic blunt-tip needles. Electrospinning
was conducted at 2 mL h1, from a distance of 18 cm
and by applying electrical voltage between 15–18 kV.
The scaffolds were processed at room temperature (RT)
and then dried for at least 48 h (Bottino et al. 2013a).
Scanning electron microscopy (SEM, JSM-5310LV,
JEOL, Tokyo, Japan) was used to evaluate the morpho-
logical aspect of the synthesized scaffolds (Bottino et al.
2013a).
Drug release
Four scaffolds (15 9 15 mm2) per group were
initially weighed and incubated in 10 mL of phos-
phate-buffered saline (PBS, pH 7.4, Fisher Scientific,
Pittsburgh, PA, USA) and kept in an incubator at
37 °C. Aliquots (1 mL) of each sample were collected
at different time-points (1, 2, 5, 7 and 14 days).
Equal amounts of fresh PBS were added back to the
incubation media subsequent to each aliquot retrieval
(Bottino et al. 2013a). HPLC–UV analysis was per-
formed on an Agilent 1100 system (Palo Alto, CA,
USA), using a Zorbax SB-phenyl chromatography col-
umn (5 lm, 150 9 4.6 mm i.d) with a 10-lL injec-
tion volume. A binary mobile phase consisting of
solvent systems A and B were used in gradient elu-
tion where A was 0.1% formic acid (v/v) in ddH2O
and B was 0.1% formic acid (v/v) in acetonitrile. The
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mobile phase flow rate was 1.0 mL min1. Initial
conditions were set at 95 : 5 A:B, followed by a linear
gradient to 40 : 60 from 0 to 15 min. Gradient
conditions were re-equilibrated to 95 : 5 A:B from 15
to 16 min and held for 8 min at initial conditions
until 23 min. Following separation, the column efflu-
ent was introduced into a UV–Vis photodiode array
detector (Agilent). Quantitation wavelengths were
319 nm for MET and 278 nm for CIP. Retention
times for MET and CIP were 5.4 min and 7.8 min,
respectively. Standard curves for MET and CIP were
generated using authentic standards, over a concen-
tration range of 7–280 lg mL1, and then, the drug
concentration in the aliquots was calculated. Drug-
release data are shown as the mean value plus or
minus the standard deviation (SD) of the mean.
The percentage of the released drugs was then calcu-
lated based on the initial weight of the drug incorpo-
rated into the electrospun scaffolds (Bottino et al.
2013a).
Exposure of hDPSC to antibiotic-containing
scaffolds
Low glucose Dulbecco’s Modified Eagle’s Medium
(DMEM, Gibco, Grand Island, NY, USA), supplemented
with 10% fetal bovine serum (FBS, Hyclone, Logan, UT,
USA) and 1% penicillin–streptomycin (Sigma-Aldrich)
in a humidified incubator at 37 °C, with 5% CO2, was
used to culture hDPSC (catalogue number – DP003F,
AllCells LLC, Alameda, CA, USA) obtained from perma-
nent third molars. The medium was changed every
2–3 days, and cells at passages 4–6 were used.
Electrospun samples (15 9 15 mm2, n = 4/group)
cut from the distinct antibiotic-containing scaffolds
and the control (pure PDS) were mounted in a plastic
device (CellCrownTM, Scaffdex, Tampere, Finland), dis-
infected in 70% ethanol for 30 min and rinsed twice
in sterile phosphate buffer saline (PBS, Sigma-Aldrich).
Meanwhile, hDPSCs were harvested by trypsinization,
counted and seeded in 24-well plates at a density of
104/well (in 1500 lL of culture medium) on cell cul-
ture coverslips (Thermo Scientific Nunc, Rochester,
NY, USA). After a 4-h incubation period to allow the
cells to be attached, the plastic crowns with scaffolds
were introduced into the wells. For standardization
purposes, the crowns were separated from the bottom
of the plate by a 2-mm distance achieved using plastic
rings. Control (blank) columns were prepared with
medium without cells and medium with cells but with-
out any scaffolds (100% survival). In all the controls,
for quality purposes, the crowns without scaffolds were
introduced. As previously explained, a saturated solu-
tion of MET and CIP in complete culture media was
used as an equivalent of the DAP (toxic control). The
antibiotics were mixed at a concentration of
50 mg mL1 of each antibiotic (Sabrah et al. 2013).
Then, the solution was stirred for 4 h at RT, centri-
fuged at 1425 g for 15 min, and supernatant was fil-
ter-sterilized with a 0.22-lm syringe filter.
Evaluation of hDPSCs proliferation and viability
To assess the effects of antibiotic-containing scaffolds
on hDPSC proliferation, the WST-1 assay (Roche Diag-
nostics, Mannheim, Germany) was used according to
the manufacturer’s protocol. Briefly, after 3, 5 and
7 days, the CellCrownsTM were removed and 500 lL of
culture media was left in the wells, following the addi-
tion of WST-1 reagent at the ratio of 10 : 1. After 2 h
of incubation in 5% CO2 in a humidified atmosphere at
37 °C, the samples were transferred (100 lL) into 96-
well plates. Full media with cells without exposure to
scaffolds was assigned as the positive control, and full
media without cells was used as the negative control.
The optical density (OD) of the incorporated dye was
measured by reading the absorbance at 450 nm in a
microplate reader against a blank column (Allam et al.
2011, Bottino et al. 2013b). Cell proliferation was cal-
culated as a ratio of OD from experimental value to
positive control, both subtracted by negative control
(Allam et al. 2011, Bottino et al. 2013b).
LIVE/DEAD assay (Molecular Probes, Invitrogen,
Eugene, OR, USA) was used to assess the effects of
antibiotic-containing scaffolds on hDPSC viability
(Kim et al. 2013). Five samples for each experimental
group were analysed at day 3 of exposure according
to the manufacturer’s instructions. To obtain a nega-
tive control, cells were treated with 70% methanol for
30 min and cells with no treatment were prepared as
a positive control. In brief, LIVE/DEAD assay uses
calcein and ethidium homodimer (EthD-1). Calcein is
converted into green product by intracellular esterase,
which is active only in viable cells. By contrast,
EthD-1, a red staining, has an affinity to nuclei.
Nonetheless, to enter the nucleus, the cell membrane
must be disrupted. As a result, EthD-1 is detected only
in dead cells. Excitation and emission values for calce-
in and EthD-1 are 494/517 nm and 528/617 nm,
respectively. Briefly, after warming LIVE/DEAD
reagent stock solutions to RT, 20 lL of 2 m mol L1
EthD-1 was mixed with 10 mL of sterile PBS to obtain
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a 4 l mol L1 EthD-1 solution. Next, 5 lL of the
component A (4 m mol L1 calcein stock solution)
was added to the 10 mL of 4 l mol L1 EthD-1 solu-
tion, yielding a 2 l mol L1 calcein AM solution.
100 lL of the LIVE/DEAD working solution was
added to each well, followed by incubation at RT for
30 min. Immediately after all staining procedures (in
the dark room), the cells were evaluated directly in
the 24-well plates using an inverted fluorescence
microscope (Leica DMI 4000B, Wetzlar, Germany) at
25 9 magnification with filters 480/527 and 546/
600 for excitation/emission, respectively. At least six
pictures per group were acquired and analysed using
Image-J software (NIH, Bethesda, MD, USA).
Statistical analysis
Drug-release data were analysed by the Student’s t-test.
Data obtained from proliferation were analysed by
one-way ANOVA. Tukey’s post hoc test was used to com-
pare differences amongst the groups at the same time-
point. The level of significance was set at a = 0.05.
Results
Fibre morphology and drug release
Scanning electron microscopy (SEM) was used to
examine the effect of drug(s) (MET, CIP and MET/CIP
mixtures) incorporation on the fibre morphology of
the various antibiotic-containing scaffolds synthesized
via electrospinning. The results showed a submicron
fibre diameter for all electrospun scaffolds. More
importantly, fibres of the antibiotic-containing
scaffolds had a visibly smaller mean fibre diameter
than pure PDS (Fig. 1).
Drug-release profiles from each group of antibiotic-
containing scaffolds were examined using HPLC. The
(a) (b)
(c) (d)
(e) (f)
Figure 1 (a–f) Representative SEM images of the electrospun antibiotic-containing scaffolds (5000 9 magnification): (a) Pure
PDS, (b) Pure MET, (c) 3 : 1MET/CIP, (d) 1 : 1MET/CIP, (e) 1 : 3MET/CIP and (f) Pure CIP.
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mean drug release, as well as the percentage (%) of
drug release, was assessed up to 2 weeks as an initial
screening of the potential ability of these scaffolds to
function as drug delivery systems. A burst drug(s)
release was noted within the first 24 h in all samples.
The initial burst release was followed by an overall
linear and sustained maintenance of the drug(s) con-
centration in the incubation media throughout the
14 days (Fig. 2). The mean MET drug released after
14 days for pure MET, 3 : 1 MET/CIP, 1 : 1 MET/CIP
and 1 : 3 MET/CIP were 1870  663.1 lg,
1260  229 lg, 1068  305.9 lg and 536 
71.6 lg, respectively (Fig. 2a). Meanwhile, the per-
centage (%) of MET drug released after 14 days was
63% (3 : 1 MET/CIP), 69% (pure MET) and 93% for
the 1 : 1 MET/CIP scaffolds (Fig. 2b). 1 : 1 MET/CIP
scaffolds released all MET content by day 5 (Fig. 2b).
The mean CIP drug released after 14 days for pure
CIP, 3 : 1 MET/CIP, 1 : 1 MET/CIP and 1 : 3 MET/
CIP were 966  166.6 lg, 418  96.8 lg, 674 
105 lg and 900  96.8 lg, respectively (Fig. 2c).
After 14 days, the percentage (%) of CIP drug
released ranged from 32% for pure CIP to 63% for
3 : 1 MET/CIP scaffolds (Fig. 2d). No statistical differ-
ences in mean CIP release between pure CIP
and 1 : 3 MET/CIP scaffolds (Fig. 2b) were observed.
The percentage of CIP drug release was signifi-
cantly lower (P < 0.05) in pure CIP when compared
(a) (b)
(c) (d)
Figure 2 (a–d) Graphs represent both MET and CIP drug release for all antibiotic-containing scaffolds. (a) Mean MET drug
release (in lg, SD, refer to inset Table). (b) Percentage of MET drug release (SD, refer to inset Table) from the scaffolds based
on initial weight. (c) Mean CIP drug release (in lg, SD, refer to inset Table). (d) Percentage of CIP drug release (SD, refer to
inset Table) from the scaffolds based on initial weight.
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to all other groups at all time-points investigated
(Fig. 2d).
Human DPSCs proliferation and viability
The WST-1 proliferation assay was used to determine
the indirect effects (i.e. drug(s) release) of antibiotic-
containing scaffolds on hDPSCs proliferation. In brief,
the colorimetric-based WST-1 assay makes use of a tet-
razolium salt that generates a very water-soluble for-
mazan upon cellular reduction (Tominaga et al.
1999). The results of the assay revealed a significant
(P < 0.05) decrease in proliferation for all groups
exposed to CIP-containing scaffolds (Fig. 3) at all time-
points, in a concentration-dependent manner. In con-
trast, groups exposed to MET and pure PDS showed no
change in proliferation. In this study, LIVE/DEAD
assay was performed specifically to qualitatively evalu-
ate cell morphology and viability after 3 days of scaf-
fold exposure. Analysis of hDPSC viability by
fluorescence microscopy revealed important differences
amongst the groups. Cells exposed to either pure PDS
or MET displayed a spindle-shaped fibroblastic cell body
with mainly long cellular processes, with strong sub-
strate attachment and associated multiple proliferating
cells (Fig. 4a–b). A visual decrease in cell number with
a higher % of dead cells, indicated by the colour red,
was observed after exposure to CIP-containing scaf-
folds. In addition, these cells showed a rounded form
without cytoplasmic branched projections (Fig. 4c–f).
No cells were seen after 3 days of exposure to the
DAP-mimic solution (data not shown).
Discussion
Selection of the best method for eradication of root
canal infection prior to regenerative endodontic proce-
dures should be dictated by two major outcomes, that
is the maximization of the antibacterial efficiency
whilst preserving the proliferation/differentiation
potential of pulp stem cells (Trevino et al. 2011, Mar-
tin et al. 2014). Over the past few years, a myriad of
studies has been performed (Bottino et al. 2013a,
2014, Palasuk et al. 2014, Waeiss et al. 2014) focus-
ing on the synthesis of antibiotic-containing scaffolds
based on the central hypothesis that controlling the
release rate of significantly lower (compared to the
double and triple antibiotic pastes), yet effective, anti-
biotic doses might lead to enhanced human dental
pulp stem cell viability (hDPSC), whilst preserving
antimicrobial activity.
The drug-release data indicated that after an ini-
tial burst release (i.e. within the first 24 h), a con-
tinued maintenance of the drug(s) concentration for
all time-points was observed, suggesting a sustained
level of drugs that might be effective in the eradica-
tion of existing infection. In fact, a recent study
(Palasuk et al. 2014) revealed significant antimicro-
bial activity of these novel antibiotic-containing elec-
trospun scaffolds over a 14-day period for different
bacteria, comparable to activity provided by 0.12%
chlorhexidine. Notably, the percentage of CIP was
higher for 1 : 3 MET/CIP scaffolds when compared
to those containing CIP only. This observation could
be explained by pharmacokinetic interactions of both
drugs. Solubility of MET is inversely proportional to
pH, with the lowest solubility at about pH 8.0 (Red-
iguieri et al. 2011), whereas the solubility of CIP, a
zwitterionic molecule, is optimal at neutral pH (Bre-
da et al. 2009). Thus, MET presence in 1 : 3 MET/
CIP could facilitate the release of CIP from the scaf-
folds due to physicochemical interactions. The
important differences (i.e. a sizeable standard devia-
tion) in mean fibre diameter amongst the antibiotic-
containing groups might also play an important role
in drug-release kinetics. Full optimization of the vari-
ous electrospinning conditions, such as voltage and
distance tip-collector, amongst others, will be
explored in a future investigation to reduce the fibre
diameter variability normally associated with
electrospinning.
The long-term goal of this research is to translate
into clinical practice a two-step tissue engineering-
based strategy for regenerative endodontics by first
Figure 3 Effects of pure PDS, antibiotic-containing scaffolds
and DAP on hDPSCs proliferation. Proliferation was assessed
via WST-1 assay after 3, 5 and 7 days of hDPSC exposure to
the scaffolds and DAP solution. Data were plotted with mean
(SD). Statistical analyses were compared within the results
from the same day. Correlation of upper case letter versus
lower case letter versus lower case letter with apostrophe
denotes statistical significance at the level of P < 0.05.
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establishing a bacteria-free environment conducive to
tissue regeneration (Step 1) through the use of antibi-
otic-containing scaffolds, followed by placement of a
scaffold encapsulated with growth factors and/or stem
cells (Step 2) to drive regeneration of the pulp–dentine
complex (Albuquerque et al. 2014). Data from previ-
ous studies demonstrated convincing evidence of
the antibacterial efficacy of PDS-based antibiotic-
containing scaffolds (e.g. vancomycin, rifampicin,
metronidazole, ciprofloxacin) against osteomyelitis-,
periodontitis-, and root canal infection-associated
pathogens (Bottino et al. 2013a, 2014, Palasuk et al.
2014, Waeiss et al. 2014). Here, novel antibiotic-con-
taining scaffolds were evaluated in terms of their
potential toxic effects to hDPSC using both proliferation
and viability assays. Based on the data presented, the
hypothesis was accepted, as the antibiotic-containing
scaffolds promoted significantly lower cytotoxic effects
when compared to the clinically advocated double
antibiotic paste (DAP).
Calcium hydroxide [Ca(OH2)] is considered to be an
excellent antimicrobial medication in endodontics, but
its effectiveness can be limited to the main root canal
with inadequate dentine penetration (Haapasalo &
Ørstavik 1987, Ercan et al. 2006), mostly due to low
solubility and buffering dentine characteristics (Haap-
asalo et al. 2000, Portenier et al. 2001). Recently,
antibiotic-containing pastes (i.e. TAP and DAP), at
clinically advocated concentrations, have been shown
to significantly affect the proliferation and survival of
dental pulp cells (Chuensombat et al. 2013) as well as
stem cells from the apical papilla (Ruparel et al.
2012). The present study confirms the highly toxic
effects of DAP through the proliferation and viability
(a) (b)
(c) (d)
(e) (f)
Figure 4 (a–f) Representative fluorescence microscopy images (25 9 magnification, scale bar = 100 lm) show hDPSCs viabil-
ity assessed with LIVE/DEAD assay after exposure to scaffolds for 3 days: (a) Pure PDS; (b) MET; (c) 3 : 1MET/CIP;
(d) 1 : 1MET/CIP; (e) 1 : 3MET/CIP and (f) CIP. Cellular bodies stained green show viable cells. Arrows indicate red stained
ethidium bromide-positive nuclei (dead cells).
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assays after hDPSC exposure to the DAP-mimic, MET/
CIP saturated solution.
From a clinical perspective, antimicrobials may
act unfavourably on dental stem cells via two main
mechanisms, that is diffusion to apical papilla during
time of introduction into the root canal system,
and/or by interference of residual drugs with migrat-
ing stem cells into the preformed blood clot. Of the
two drug components in DAP, no change in either
proliferation or viability of MET-only containing scaf-
folds was noticed. Even though there are studies
indicating MET as being responsible for dose-depen-
dent cytotoxic effects both in vitro (Kapoor et al.
1999) and in vivo (Chatzkel & Vossough 2010,
Kuriyama et al. 2011), it has demonstrated favour-
ing eukaryotic cell viability. MET has been shown to
increase lymphocyte proliferation (Elizondo et al.
1994); however, the mechanism is not well under-
stood. One plausible explanation is that MET can
modulate proliferation through the release of inflam-
matory cytokines as observed in human periodontal
ligament cells (Rizzo et al. 2010). Thus, MET, despite
its proven antimicrobial characteristics, could also be
considered to be a potential stem cell proliferation
inducer when delivered locally using scaffolds to
eliminate root canal infection. Regarding CIP, an
inhibitory effect of all CIP-containing polymer scaf-
folds on both proliferation and viability of hDPSCs
was observed. Dose-dependent cytotoxic effects of
antibiotics from the fluoroquinolones group, includ-
ing CIP, were described elsewhere (Sobolewska et al.
2013). Lastly, an important decrease in hDPSC via-
bility for all samples exposed to CIP with a dose-
dependent trend, where the least toxicity was seen
in cells exposed to scaffolds with the lowest CIP con-
tent (3 : 1 MET/CIP). Future studies will focus on
the determination of an optimal concentration of
CIP with minimal or no toxic effects to stem cells,
whilst still maintaining antimicrobial efficacy. In a
clinical setting, the lowest possible CIP concentration
within scaffolds with modulatory effects of MET
might lead to improvement in the survival, prolifera-
tion and regenerative capacity of dental pulp stem
cells.
Conclusion
Synthesized antibiotic-containing scaffolds had signifi-
cantly lower effects on hDPSCs’ proliferation and via-
bility when compared to the saturated CIP/MET
solution (DAP).
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